Shengjun Xu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Multidrug Resistant

Cancer Stem Cells

Top Venues

Journal of hepatocellular carcinoma

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Xun Qiu, Libin Dong, Kai Wang, Xinyang Zhong, Hanzhi Xu, Shengjun Xu, Haijun Guo, Xuyong Wei, Wei Chen, Xiao Xu
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Xun Qiu, Libin Dong, Kai Wang, Xinyang Zhong, Hanzhi Xu, Shengjun Xu, Haijun Guo, Xuyong Wei, Wei Chen, Xiao Xu
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Shengjun Xu, Sunbin Ling, Qiaonan Shan, Qianwei Ye, Qifan Zhan, Guangjiang Jiang, Jianyong Zhuo, Binhua Pan, Xue Wen, Tingting Feng, Haohao Lu, Xuyong Wei, Haiyang Xie, Shusen Zheng, Jiajia Xiang, Youqing Shen, Xiao Xu
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (5) (2021)